Lucas Bio and Korea Pasteur Institute to Jointly Develop Memory T Cell Therapy for SFTS
Expanding Development of High-Risk Virus Therapies Using Memory T Cell Platform
Lucas Bio, a cell therapy development company under the Boryung Group, is partnering with the Korea Pasteur Institute to develop a memory T cell therapy for Severe Fever with Thrombocytopenia Syndrome (SFTS).
On July 3, the two organizations announced that they have signed an agreement to jointly develop an antigen-specific memory T cell therapy candidate targeting SFTS. Through this collaboration, they plan to jointly identify therapeutic candidates and conduct preclinical efficacy evaluations, accelerating the establishment of a foundation for clinical entry.
SFTS is a tick-borne infectious disease classified as a high-risk viral infection, with both patients and fatalities reported annually in Korea. As there are currently no approved vaccines or treatments, there is a significant unmet medical need for this disease.
The Korea Pasteur Institute will be responsible for the preclinical evaluation and viral analysis of the SFTS therapy candidate. Lucas Bio will utilize its proprietary memory T cell platform technology to develop antigen-specific T cells and plans to pursue clinical entry in the future.
Lucas Bio has previously expanded the scope of its platform application based on its experience in developing multi-virus T cell therapies. With this collaboration, both organizations aim to strengthen their capabilities in developing therapies for high-risk infectious diseases and plan to expand research to a broader range of viral infections.
Jang Seungki, Director of the Korea Pasteur Institute, stated, "This joint research presents new possibilities for immune therapeutic strategies that directly target high-risk virus-infected cells. We will continue to collaborate to offer a new paradigm in the development of therapeutics for infectious diseases."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Jo Seokgu, CEO of Lucas Bio, said, "By establishing a DTK-based healthy donor memory T cell banking system, we aim to develop it into a national platform for responding to infectious diseases."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.